However, given that RagCS75Y cardiomyopathy could be ascribed to the increased Rags–TFEB binding that is independent of mTOR signaling, mTOR inhibition is also possible not to exert therapeutic benefits. The gene discussed is EFNA5; the disease is cardiomyopathy.